Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vaccine uptake needed for sheep abortion control, data shows
Seventy-nine per cent of flocks have been exposed to toxoplasmosis.

Only 26 per cent of flocks vaccinated against toxoplasmosis in 2024.

Research from the Agriculture and Horticulture Development Board (AHDB) has highlighted opportunity for farmers to increase abortion control in flocks.

The data reveals that, while uptake had already reached 50 per cent for enzootic vaccines, just 26 per cent of flocks were vaccinated against toxoplasmosis.

Although the sector has struggled with vaccine availability in the past, the board believes there is opportunity for greater protection in the national flock. Enzootic abortion and toxoplasmosis are identified by the Animal and Plant Health Agency as two of the most common causes of sheep abortion in Great Britain.

MSD Animal Health’s FlockCheck programme collected diagnostic data from 400 sheep flocks in 2025.

This data revealed that 79 per cent of flocks had been exposed to Toxoplasma gondii. Meanwhile, 35 per cent of flocks had been exposed to Chlamydia abortus, the bacterium which causes enzootic abortion.

Enzootic abortion is highly contagious, occurring primarily through feed contaminated with cat faeces. Infected ewes will show no signs until late pregnancy and can become lifetime carriers.

Since parasite eggs can survive for over a year, vaccination is considered the most reliable form of protection.

MSD Animal Health says that their results support farmers in making targeted vaccination decisions. This helps them safeguard flocks and maximise lambing outcomes.


Where abortion rates are exceeding two per cent, or scanning results prove lower than expected, farmers can get practical support through the subsidised FlockCheck scheme. The scheme, available through veterinary practices until 30 June 2026, provides blood testing for six to eight aborted or unvaccinated ewes, or for barren ewes and those producing weak lambs.

The tests will help farmers to recognise the underlying causes of abortions, as well as informing the value of a pre-tupping vaccination programme.

Dr Kat Baxter-Smith, MSD veterinary advisor, said: “If results highlight an issue with either disease, both can be controlled effectively through a simple vaccination programme,

“Abortion diseases like enzootic abortion and toxoplasmosis often remain hidden until significant losses occur. Once established, they are extremely difficult and costly to manage, making prevention through vaccination vital.”

Image © Serenity Images23/Shutterstock.com

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.